SC0245

· Biocity Biopharmaceutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SC0245, covering 2023-07-14 to 2023-07-14. Get the full timeline:

Most recent: Clinical Trial Update: SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC) [Phase 1, Phase 2]

See pricing